Literature DB >> 1615482

A novel functional assay of protein C in human plasma and its comparison with amidolytic and anticoagulant assays.

H A Guglielmone1, M A Vides.   

Abstract

A simple and fast method for the quantitative determination of protein C activity in plasma is here described. The first step consists in the conversion of protein C in the test sample into activated protein C by means of an activator isolated from Southern Copperhead venom. Subsequently, the degradation of factor Va, in presence of protein C-deficient plasma, is measured by the prolongation of the prothrombin time which is proportional to the amount of protein C in the sample. The dose-response curve showed a linear relationship from 6 to 150% protein C activity and the inter- and intra-assay reproducibility was 3.5% and 5.6% respectively. In normal subjects, a mean of protein C level of 98 +/- 15% of normal pooled plasma was found. Comparison with the anticoagulant assay in samples of patients with oral anticoagulant, liver cirrhosis, disseminated intravascular coagulation and severe preeclampsia revealed an excellent correlation (r = 0.94, p less than 0.001). Also, a similar correlation (r = 0.93, p less than 0.001) existed between amidolytic assay and the method here proposed for all the samples studied without including the oral anticoagulant group. These results allowed us to infer that this method evaluates the ability of protein C to interact with protein S, phospholipids, calcium ions and factor Va.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1615482

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis.

Authors:  A J Tafur; G Dale; M Cherry; J D Wren; A S Mansfield; P Comp; S Rathbun; J A Stoner
Journal:  Thromb Res       Date:  2015-10-08       Impact factor: 3.944

2.  Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans.

Authors:  Tom van der Poll; Marcel Levi; Jerry A Nick; Edward Abraham
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

3.  Laboratory Limitations of Excluding Hereditary Protein C Deficiency by Chromogenic Assay: Discrepancies of Phenotype and Genotype.

Authors:  Holger Seidel; Bianca Haracska; Jennifer Naumann; Philipp Westhofen; Moritz Sebastian Hass; Johannes Philipp Kruppenbacher
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

4.  Haemostatic parameters, platelet activation markers, and platelet indices among regular plateletpheresis donors.

Authors:  Hulwani T M Tuan; Lim S Hock; Zaidah W Abdullah
Journal:  J Taibah Univ Med Sci       Date:  2017-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.